Literature DB >> 8731215

Comparison and quantitation of wear debris of failed total hip and total knee arthroplasty.

K Hirakawa1, T W Bauer, B N Stulberg, A H Wilde.   

Abstract

To compare the physical properties of debris particles associated with failed total hip and total knee arthroplasty, we applied a recently developed assay to electronically characterize the size, number, and composition of debris particles isolated from tissues adjacent to failed implants. We identified 21 samples (from 20 patients) of hip synovia and 35 samples (from 32 patients) of knee tissues that had been obtained at the time of revision arthroplasty. There were 12 females and 9 males in the hip group, and 16 females and 19 males in the knee group. Primary arthroplasty was performed for osteoarthritis (OA, 15 cases) or rheumatoid arthritis (RA, 6 cases) in the hip, and for OA (23) or RA (12) in the knee. Patients ranged in age from 23 to 85 (mean 59 years) for total hip, and from 27 to 84 (mean 61 years) for total knee arthroplasty. Implantation duration was from 5 to 123 months (mean 37.8) for total hip, and from 11 to 123 months (mean 63.1) for total knee arthroplasty. All of the implants were composed of cobalt-chromium alloy articulating with ultrahigh-molecular-weight polyethylene. The number of particles smaller than 10 microns ranged from 1.04 x 10(8)/g to 1.91 x 10(10)/g in the hip, and from 6.69 x 10(8)/g to 2.13 x 10(10)/g in the knee. Energy-dispersive X-ray spectroscopy and polarized light analysis showed both polyethylene and metal particles in most cases. The mean diameter of particles smaller than 10 microns was 0.72 +/- 0.2 microns in the hip, and 0.74 +/- 0.1 microns in the knee. Evaluation of particles larger than 10 microns showed a larger range of particle size in knee tissues (maximum 6.1 mm, mean 283 microns), than in the hip tissues (maximum 826 microns, mean 81 microns) (p < 0.001). Very small particles are common in both groups, but it appears that a larger range of particle sizes is present adjacent to failed knee than to failed hip prostheses. The higher frequency of large particles in failed knee prostheses probably reflects the perceived higher rate of delamination and fragmentation of tibial and patellar compared to that of acetabular polyethylene.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8731215     DOI: 10.1002/(SICI)1097-4636(199606)31:2<257::AID-JBM13>3.0.CO;2-I

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  27 in total

1.  [Proposal for the classification of the periprosthetic membrane from loosened hip and knee endoprostheses].

Authors:  L Morawietz; Th Gehrke; R-A Classen; B Barden; M Otto; T Hansen; Th Aigner; P Stiehl; J Neidel; J H Schröder; L Frommelt; Th Schubert; C Meyer-Scholten; A König; Ph Ströbel; Ch P Rader; S Kirschner; F Lintner; W Rüther; A Skwara; I Bos; J Kriegsmann; V Krenn
Journal:  Pathologe       Date:  2004-09       Impact factor: 1.011

Review 2.  [Histopathologic diagnostics in endoprosthetics: periprosthetic neosynovialitis, hypersensitivity reaction, and arthrofibrosis].

Authors:  V Krenn; M Otto; L Morawietz; T Hopf; M Jakobs; W Klauser; B Schwantes; T Gehrke
Journal:  Orthopade       Date:  2009-06       Impact factor: 1.087

3.  [Joint endoprosthesis pathology. Histopathological diagnostics and classification].

Authors:  V Krenn; L Morawietz; M Jakobs; H Kienapfel; R Ascherl; L Bause; H Kuhn; G Matziolis; M Skutek; T Gehrke
Journal:  Pathologe       Date:  2011-05       Impact factor: 1.011

4.  Proposal for a histopathological consensus classification of the periprosthetic interface membrane.

Authors:  L Morawietz; R-A Classen; J H Schröder; C Dynybil; C Perka; A Skwara; J Neidel; T Gehrke; L Frommelt; T Hansen; M Otto; B Barden; T Aigner; P Stiehl; T Schubert; C Meyer-Scholten; A König; P Ströbel; C P Rader; S Kirschner; F Lintner; W Rüther; I Bos; C Hendrich; J Kriegsmann; V Krenn
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

5.  [Revised consensus classification. Histopathological classification of diseases associated with joint endoprostheses].

Authors:  V Krenn; L Morawietz; H Kienapfel; R Ascherl; G Matziolis; J Hassenpflug; M Thomsen; P Thomas; M Huber; C Schuh; D Kendoff; D Baumhoer; M G Krukemeyer; G Perino; J Zustin; I Berger; W Rüther; C Poremba; T Gehrke
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

6.  [Supramacroparticulate polyethylene in inflammation of synovial-like interface membranes: Characterization and suggested nomenclature].

Authors:  V Krenn; F Hopf; P Thomas; M Thomsen; S Usbeck; F Boettner; S Müller; D Saberi; T Hügle; M Huber; L Scheuber; J C Hopf; J P Kretzer
Journal:  Orthopade       Date:  2016-03       Impact factor: 1.087

7.  Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat model.

Authors:  Chen-He Zhou; Zhong-Li Shi; Jia-Hong Meng; Bin Hu; Chen-Chen Zhao; Yu-Te Yang; Wei Yu; Ze-Xin Chen; Boon Chin Heng; Virginia-Jeni Akila Parkman; Shuai Jiang; Han-Xiao Zhu; Hao-Bo Wu; Wei-Liang Shen; Shi-Gui Yan
Journal:  Br J Pharmacol       Date:  2018-02-14       Impact factor: 8.739

8.  Macrophage polarization in response to wear particles in vitro.

Authors:  Joseph K Antonios; Zhenyu Yao; Chenguang Li; Allison J Rao; Stuart B Goodman
Journal:  Cell Mol Immunol       Date:  2013-09-09       Impact factor: 11.530

9.  Peri-Implant Distribution of Polyethylene Debris in Postmortem-Retrieved Knee Arthroplasties: Can Polyethylene Debris Explain Loss of Cement-Bone Interlock in Successful Total Knee Arthroplasties?

Authors:  Karen I Cyndari; Jacklyn R Goodheart; Mark A Miller; Megan E Oest; Timothy A Damron; Kenneth A Mann
Journal:  J Arthroplasty       Date:  2017-02-03       Impact factor: 4.757

10.  [Histopathological differential diagnostics in context of joint implant allergic reactions].

Authors:  V Krenn; C Poremba; J Schneider; D Kendoff; T Gehrke; J P Kretzer; M Thomsen; M Huber
Journal:  Orthopade       Date:  2013-08       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.